Predictors of pregnancy in women with endometriosis based on endometrial assessment
Journal of obstetrics and women's diseases · 23.06.2026 · 75 (3) · 28-37
DOI: 10.17816/jowd706284 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of obstetrics and women's diseases, online erschienen am 23.06.2026. Verfasst von Lyailya Kh. Dzhemlikhanova und 4 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Although clinical evidence remains inconsistent, growing data suggest that endometriosis is associated with molecular, hormonal, and immune-inflammatory alterations in the eutopic endometrium that may impair endometrial receptivity. Therefore, assessment of eutopic endometrial status in women with endometriosis is important for clarifying the mechanisms underlying the reduced implantation rate. AIM: The aim of this study was to evaluate the impact of eutopic endometrial status on in vitro fertilization / intracytoplasmic sperm injection (IVF/ICSI) outcomes in women with endometriosis, including depending on previous hormonal treatment for endometriosis. METHODS: This comparative study enrolled 111 women with endometriosis scheduled for IVF/ICSI. The control group comprised 85 women without signs of the disease. All participants underwent endometrial biopsy, followed by histological and immunohistochemical assessment, including evaluation of estrogen receptor, progesterone receptor, CD8, CD20, and CD138 expression. IVF/ICSI was performed 1–3 months after biopsy, with the clinical pregnancy rate used as the main outcome measure. RESULTS: Women with endometriosis and controls were comparable in age, menstrual characteristics, and reproductive history. However, the clinical pregnancy rate after IVF/ICSI was lower in women with endometriosis than in controls (31.5% vs. 45.9%, p = 0.045). In patients with endometriosis who received hormonal therapy before IVF/ICSI, complete secretory transformation of the endometrium and higher progesterone receptor expression were observed more frequently, and the clinical pregnancy rate was higher than in women without previous hormonal treatment (40.0% vs. 21.6%, p = 0.043). Women with the stage III–IV disease who had not received hormonal therapy showed reduced stromal progesterone receptor expression and increased CD8+, CD20+, and CD138+ expressions. Previous hormonal treatment and complete secretory transformation of the endometrium were identified as the main favorable prognostic factors for IVF/ICSI outcome in women with endometriosis. CONCLUSION: Advanced endometriosis is associated with impaired secretory transformation of the endometrium and reduced progesterone receptor expression. Hormonal treatment before IVF/ICSI appears to improve endometrial receptivity and pregnancy outcomes. Multiple discriminant analysis revealed a high predictive value for clinical pregnancy rates when hormonal therapy for endometriosis was used within 12 months prior to the start of the IVF/ICSI program.
Zitieren
APA
Dzhemlikhanova, L. K., Gzgzyan, A. M., Niauri, D. A., Tolibova, G. K., & Abdulkadyrova, Z. K. (2026). Predictors of pregnancy in women with endometriosis based on endometrial assessment. Journal of obstetrics and women's diseases, 75(3), 28-37. https://doi.org/10.17816/jowd706284
Vancouver
Dzhemlikhanova LK, Gzgzyan AM, Niauri DA, Tolibova GK, Abdulkadyrova ZK. Predictors of pregnancy in women with endometriosis based on endometrial assessment. Journal of obstetrics and women's diseases. 2026;75(3):28-37. doi:10.17816/jowd706284
BibTeX
@article{Dzhemlikhanova2026,
author = {Dzhemlikhanova, Lyailya Kh. and Gzgzyan, Alexander M. and Niauri, Dariko A. and Tolibova, Gulrukhsor Kh. and Abdulkadyrova, Zarina K.},
title = {Predictors of pregnancy in women with endometriosis based on endometrial assessment},
journal = {Journal of obstetrics and women's diseases},
year = {2026},
volume = {75},
number = {3},
pages = {28--37},
doi = {10.17816/jowd706284}
}
EUVIMED